Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
aboutHyStem, absorption, AccountingIn, acuity, administerReGlyde, AEs, Aflibercept, agex, aHyStem, Alfred, AllRenevia, amelioration, amenable, AMT, anda, andAssociation, andIsrael, andOphthalmology, andOpRegen, andPremvia, andReGlyde, andRenevia, anotherHyStem, asRenevia, Assumption, atLifeMap, BCVA, becameeffective, BecauseHextend, BioTimeHyStem, bleb, bolster, bookkeeping, Boyer, burdensome, cannula, carryforward, Chairman, charity, Chart, Chicago, clarified, Coast, coherence, complicating, conclusion, conduced, conductingDetermaVu, consecutive, Corrupt, coveringHextend, coveringOpRegen®through, CureOpRegen, Curesection, cystectomy, David, deadly, dedicated, defense, deliveryandcell, deprive, deter, determinedbased, deterring, detrimental, developingHyStem, developingHyStem®for, developingRenevia, disagree, dissolved, domain, dropping, dueto, eitherHyStem, eitherHyStem®scaffold, elapsed, eliciting, epiretinal, EPO, ERM, excessive, expectOpRegen, expiry, exploratory, extraordinary, Eylea, FCPA, fellow, FIH, footage, forHextend, forHyStem®hydrogel, forOncoCyte, forOpRegen, forOpRegen®in, forRenevia, frommobile, GA, gateway, gel, gerontology, gradual, hemifacial, HITECH, hyaluronate, hyperreflectance, HyStem®Delivery, IASLC, IIB, immortality, immunotherapeutic, Importantly, imposition, impractical, inaction, inadvisable, includingHextend, includingHextend®should, includingOpRegen, includingRenevia, inconsistent, infrastructure, inHextend, inInternal, inMayo, inOpRegen, inRenevia®may, insignificant, insufficient, intervention, interventional, intraarticular, irregular, ischemia, isincluded, isOpRegen, isRenevia, itsOpRegen®program, jeopardized, journalRegenerative, Kingsley, leader, liabilityon, lump, makeHyStem, manufactureHextend, manufactureOpRegen, manufacturesHextend®for, manufacturingHextend, marketsHespan, marketsVoluven, markup, McDonald, MD, merit, mid, mild, millionin, millionprimarily, mind, misuse, multicenter, Multidisciplinary, mutual, nutritional, occasion, ofapproximately, ofDetermaVu, offshore, ofHespan, ofHextend, ofHextend®have, ofOpRegen, ofOpRegen®in, ofOpRegen®through, ofPremvia, ofPureStem, ofRenevia, ofRenevia®for, ofRenevia®or, omission, OncoCytebelow, onOpRegen, onRenevia, orin, OrthoCyteoption, otherHyStem, otherin, ourHyStem, ourOpRegen, ourOpRegen®product, ourPremvia, ourPremvia®product, overview, Patch, patentsto, PCAOB, penalty, penetration, perspective, photographic, photoreceptor, precautionary, produceOpRegen, produceOpRegen®and, profession, proliferationin, propagationin, proportionate, proprietaryHyStem®cell, proprietaryPureStem, proprietaryPureStem®human, providesufficient, provisional, PureStem®progenitor, purification, Ranibizumab, reacquisition, rectification, Reflectstheeffect, refund, refundable, regain, relationship, remeasured, remeasurement, Renevia®met, repatriated, repatriation, repeated, Researchprogram, respectivelyBioTime, RMAT, runDetermaVu, satisfaction, scenario, sellHextend, slated, sodium, solutionHextend®for, spectral, spent, spinoff, stockat, strict, sum, sunshine, swap, taxation, taxpayer, telomere, tenor, textDetermaVu, thatHextend, theBioTime, theDetermaVu, thehystem, theHyStem®family, theopregen, theOpRegen®development, TheOpRegen®program, theOpRegen®trial, thePureStem®technology, thereunder, thickening, toOpRegen, toOpRegen®program, toRenevia, tothe, transplantedOpRegen, unaffiliated, unannounced, unanticipated, unconsolidated, underStaff, uninterrupted, unstable, usingPureStem, utilizingPureStem®cell, variance, vitrectomy, volumetric, whatsoever, withAccounting, withASC, withNoncontrolling, withOpRegen, worsening
Removed:
Asia, attainment, attorney, authorize, avascular, Bay, beneath, biomedical, biopharmaceutical, biosimilar, calculating, Canadian, cervical, characterize, charitable, chronic, College, colon, column, confidential, consented, consummated, contractor, convert, converted, converting, Cornell, credited, de, decreasing, defer, denial, deposited, differentiating, diligently, disruption, donate, ECM, elderly, electrical, Embryology, encourage, endoderm, endodermal, entertainment, entitle, environment, feasibility, Fertilisation, fertilized, Fremont, frequently, fulfill, functionally, fuse, gamete, gave, gelation, goodwill, gut, half, harming, harvested, Hespan, Hextend, hundred, import, imported, inappropriate, inclusion, integrating, intermediate, introducing, journal, launching, legislative, lesser, lineage, localizing, managed, mandated, Mayo, Merton, MKT, mobility, modern, morbidity, musculoskeletal, negotiating, Neuroscience, ninety, noncompetitive, North, nuclear, operative, organize, osteochondral, ovarian, overseen, painlessly, participating, placement, possessing, powerful, prerequisite, prioritizing, proceed, proliferation, PureStem, Rafii, randomized, rationale, realize, rebate, recover, recruiting, refine, refusal, region, residual, risky, RNA, screen, Secretary, sequencing, Shahin, sharp, shift, situ, somatic, sort, Spain, sprouting, stored, structurally, Subretinally, successor, telecommunication, telephone, terrorism, thirty, Title, tool, travel, upper, VarElect, vast, vertebrae, vi, viability, ViaCyte, virtually, Voluven, war, week, Weill, yield
Filing tables
Filing exhibits
Related press release
Associated LCTX transcripts
LCTX similar filings
Filing view
External links